We are live on ! Find out more
RCUS icon

Arcus Biosciences
RCUS

139 hedge funds and large institutions have $1.03B invested in Arcus Biosciences in 2020 Q2 according to their latest regulatory filings, with 59 funds opening new positions, 48 increasing their positions, 24 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

421% more call options, than puts

Call options by funds: $3.44M | Put options by funds: $661K

392% more first-time investments, than exits

New positions opened: 59 | Existing positions closed: 12

176% more capital invested

Capital invested by funds: $375M → $1.03B (+$660M)

100% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 24

51% more funds holding

Funds holding: 92 → 139 (+47)

14.61% more ownership

Funds ownership: 58.73% → 73.34% (+15%)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

Holders
139
Holders Change
+47
Holders Change %
+51.09%
% of All Funds
2.85%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
59
Increased
48
Reduced
24
Closed
12
Calls
$3.44M
Puts
$661K
Net Calls
+$2.78M
Net Calls Change
+$2.79M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$70.9M
2
BI
BVF Inc
California
+$49.8M
3
EC
EcoR1 Capital
California
+$41M
4
FCM
Farallon Capital Management
California
+$27M
5
State Street
State Street
Massachusetts
+$25.5M

Top Sellers

1
PS
Peter Svennilson
-$47.9M
2
BC
Boxer Capital
California
-$27M
3
Verition Fund Management
Verition Fund Management
Connecticut
-$6.35M
4
ACM
Aisling Capital Management
New York
-$4.63M
5
HA
HHLR Advisors
Cayman Islands
-$3.84M
Name Holding Trade Value Shares
Change 		Change in
Stake
SG Americas Securities
101
SG Americas Securities
New York
$363K +$80K +2,965 +25%
ZIM
102
Zacks Investment Management
Illinois
$352K +$384K +14,243 New
Voloridge Investment Management
103
Voloridge Investment Management
Florida
$345K +$377K +13,962 New
SO
104
STRS Ohio
Ohio
$329K +$359K +13,300 New
IA
105
IndexIQ Advisors
New York
$317K -$33.6K -1,246 -9%
VEA
106
Virtus ETF Advisers
New York
$312K +$340K +12,599 New
PHK
107
Point72 Hong Kong
Hong Kong
$307K +$335K +12,406 New
State Board of Administration of Florida Retirement System
108
State Board of Administration of Florida Retirement System
Florida
$298K +$16.9K +626 +5%
SEI Investments
109
SEI Investments
Pennsylvania
$295K +$322K +11,938 New
Legal & General Group
110
Legal & General Group
United Kingdom
$284K +$175K +6,476 +130%
MLICM
111
Metropolitan Life Insurance Company (MetLife)
New York
$283K +$7.45K +276 +2%
VOYA Investment Management
112
VOYA Investment Management
Georgia
$283K -$145K -5,372 -32%
DC
113
Diametric Capital
Massachusetts
$275K -$68.6K -2,541 -19%
Susquehanna International Group
114
Susquehanna International Group
Pennsylvania
$271K +$296K +10,958 New
GCP
115
GSA Capital Partners
United Kingdom
$233K -$645K -23,902 -72%
PCA
116
Personal Capital Advisors
California
$232K +$254K +9,395 New
ASRS
117
Arizona State Retirement System
Arizona
$206K +$225K +8,337 New
Russell Investments Group
118
Russell Investments Group
United Kingdom
$200K +$219K +8,100 New
NIT
119
NumerixS Investment Technologies
British Columbia, Canada
$198K +$216K +8,002 New
DCM
120
Dupont Capital Management
Delaware
$190K +$207K +7,688 New
PCM
121
Prelude Capital Management
New York
$187K -$22.5K -834 -10%
FC
122
FORA Capital
Florida
$134K +$146K +5,408 New
UBS Group
123
UBS Group
Switzerland
$92K -$468K -17,324 -82%
BNP Paribas Financial Markets
124
BNP Paribas Financial Markets
France
$85.4K -$177K -6,574 -66%
Bank of Montreal
125
Bank of Montreal
Ontario, Canada
$78K +$71.2K +2,638 +615%
3 4
5
6 7

RCUS Hedge Fund Activity: Q2 2020 in Review

139 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Arcus Biosciences (RCUS) for Q2 2020, worth a combined $1.03B — up 176% from $375M a quarter earlier.

Buyers outnumbered sellers: 59 funds opened new RCUS positions and 12 closed out — a net gain of 47 holders — while 48 added to existing stakes and 24 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $70.9M. The largest seller was Peter Svennilson, cutting an estimated $47.9M.

  • 139 institutional investors held Arcus Biosciences (RCUS) as of Q2 2020, up from 92 in Q1 2020.
  • Funds reported $1.03B of Arcus Biosciences stock for Q2 2020, up 176% quarter-over-quarter.
  • 59 funds opened new Arcus Biosciences positions in Q2 2020 and 12 closed out, a net change of +47 holders.
  • The largest Arcus Biosciences buyer in Q2 2020 was Fidelity Investments, an estimated $70.9M added.
  • The largest Arcus Biosciences seller in Q2 2020 was Peter Svennilson, an estimated $47.9M sold.

Based on aggregated 13F filings for Q2 2020.